Lv51
1030 积分 2024-07-22 加入
CAR Binders Affect CAR T-cell Tonic Signaling, Durability, and Sensitivity to Target
1个月前
已完结
CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challenges
2个月前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
2个月前
已完结
Should CAR-T cells be used as monotherapy?
2个月前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
2个月前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
3个月前
已完结
CAR-T entering a new “phase”: Improving CAR-T function by harnessing phase separation
4个月前
已完结
Transforming TGF-β suppression into IL-15 stimulation: Advancing engineered CAR-T therapy for solid tumors
4个月前
已完结
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
5个月前
已完结
Deciphering the response to BCMA CAR T cell therapy
8个月前
已完结
皖公网安备34019202002308
